Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Up 220.0% in October

by · The Markets Daily

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWMGet Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 1,600 shares, an increase of 220.0% from the September 30th total of 500 shares. Based on an average daily volume of 4,500 shares, the days-to-cover ratio is presently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Trading Down 0.2 %

HROWM traded down $0.05 on Friday, hitting $26.20. The company had a trading volume of 4,897 shares, compared to its average volume of 4,125. The business’s fifty day simple moving average is $26.54 and its 200 day simple moving average is $26.38. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12-month low of $22.71 and a 12-month high of $27.72.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be paid a $0.7422 dividend. This represents a $2.97 annualized dividend and a dividend yield of 11.33%. The ex-dividend date of this dividend is Tuesday, October 15th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

(Get Free Report)

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.

See Also